Last reviewed · How we verify

NCT07052019

Pain Perception and Anxiety With Virtual Reality vs Tell-Show-Do in Children With MIH

Not yet recruiting NA Last updated 4 July 2025
What this trial tests

NA trial testing Virtual Reality Distraction in Molar Incisor Hypomineralization in 50 participants. Not yet recruiting.

Timeline
1 August 2025
Primary endpoint
1 October 2025
1 December 2025

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposetreatment
Enrollment50
Start date1 August 2025
Primary completion1 October 2025
Estimated completion1 December 2025
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 6 to 12, any sex, with Molar Incisor Hypomineralization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This pilot crossover randomized clinical trial aims to compare the effect of distraction using Virtual Reality (VR) versus the Tell-Show-Do (TSD) technique on pain perception and anxiety in children aged 6-12 with Molar Incisor Hypomineralization (MIH) undergoing restorative dental treatment.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Virtual Reality Distraction

Trials testing the same drug.

Other recruiting trials for Molar Incisor Hypomineralization

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07052019.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing